T-Cypher Bio
PrivateLast Round
Seed
Feb 25, 2021
Total Funding Raised
$42.3M
Company Overview
T-Cypher Bio is a biotechnology company that develops a pipeline of novel, T-cell receptor (TCR)-based therapeutics for solid tumours, autoimmune, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T-Cypher Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
T-Cypher Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 25, 2021 | ||||
| Series A | Feb 25, 2021 |
Key People
Founding team and executive leadership
T-Cypher Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Science Enterprises | Series A, Seed |
| University of Oxford | Series A, Seed |
| Borealis Ventures | Series A, Seed |
| Rio Tinto Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2024
Grew 20% QoQ, from 25 to 30 employees.
- Apr 12, 2024
Grew 30% QoQ, from 23 to 30 employees.
T-Cypher Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about T-Cypher Bio's valuation, stock price, and market status.